Study Assessing Safety, Efficacy of Experimental Treatment in Metastatic Prostate Cancer Adds Additional Trial Sites

by admin_63069 | Nov 16, 2022 | News You Can Use

The study investigators will review the efficacy of [Lu-177]-PNT2002, a radioligand treatment, compared with Zytiga or Xtandi in patients with metastatic castration-resistant prostate cancer.